Literature DB >> 10366103

Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression.

S Thornton1, L E Duwel, G P Boivin, Y Ma, R Hirsch.   

Abstract

OBJECTIVE: To quantitate changes in cytokine and chemokine messenger RNA (mRNA) levels during the development and progression of collagen-induced arthritis (CIA) in mice.
METHODS: Mice with CIA were scored for arthritis and killed at weekly intervals. Cytokine and chemokine mRNA levels were determined by RNase protection assays of total paw RNA.
RESULTS: Arthritic paws exhibited mRNA levels of interleukin-1beta (IL-1beta), IL-2, macrophage inflammatory protein 2 (MIP-2), IL-6, IL-1 receptor antagonist, RANTES, tumor necrosis factor alpha (TNFalpha), TNFbeta, MIP-1alpha, IL-11, transforming growth factor beta1 (TGFbeta1), TGFbeta2, and TGFbeta3 that were increased above mRNA levels in paws of normal, unimmunized mice and that exhibited distinct temporal patterns of mRNA expression. Clinically uninvolved paws also exhibited an increase in mRNA levels of IL-11, RANTES, TNFalpha, TNFbeta, and MIP-1alpha.
CONCLUSION: The observed differential temporal cytokine and chemokine mRNA expression patterns suggest that specific cytokines and chemokines have defined roles at various times during the course of autoimmune arthritis. Since most of these cytokines and chemokines are found in human rheumatoid arthritis (RA) synovium and synovial fluids, these findings may have relevance to RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366103     DOI: 10.1002/1529-0131(199906)42:6<1109::AID-ANR7>3.0.CO;2-7

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  46 in total

Review 1.  Analysing the effect of novel therapies on cytokine expression in experimental arthritis.

Authors:  Richard O Williams; Julia J Inglis; Egle Simelyte; Gabriel Criado; Percy F Sumariwalla
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

2.  TGF-β type II receptor/MCP-5 axis: at the crossroad between joint and growth plate development.

Authors:  Lara Longobardi; Tieshi Li; Timothy J Myers; Lynda O'Rear; Huseyin Ozkan; Ying Li; Clara Contaldo; Anna Spagnoli
Journal:  Dev Cell       Date:  2012-07-17       Impact factor: 12.270

3.  Amelioration of collagen-induced arthritis by thrombin inhibition.

Authors:  I Marty; V Péclat; G Kirdaite; R Salvi; A So; N Busso
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 5.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

6.  Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.

Authors:  Mengyuan Liu; Xiangbin Wang; Changcheng Yin; Zhong Zhang; Qing Lin; Yongsu Zhen; Hualiang Huang
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

7.  Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies.

Authors:  T McNearney; B A Baethge; S Cao; R Alam; J R Lisse; K N Westlund
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  The destruction evaluation in different foot joints: new ideas in collagen-induced arthritis rat model.

Authors:  Peng Zhang; Dong Han; Tingting Tang; Xiaoling Zhang; Kerong Dai
Journal:  Rheumatol Int       Date:  2008-11-04       Impact factor: 2.631

9.  Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment.

Authors:  I Rioja; K A Bush; J B Buckton; M C Dickson; P F Life
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.